Literature DB >> 14630827

Small lymphocytic lymphoma, marginal zone B-cell lymphoma, and mantle cell lymphoma exhibit distinct gene-expression profiles allowing molecular diagnosis.

Catherine Thieblemont1, Valéry Nasser, Pascale Felman, Karen Leroy, Sophie Gazzo, Evelyne Callet-Bauchu, Béatrice Loriod, Samuel Granjeaud, Philippe Gaulard, Corinne Haioun, Alexandra Traverse-Glehen, Lucile Baseggio, François Bertucci, Daniel Birnbaum, Florence Magrangeas, Stéphane Minvielle, Hervé Avet-Loiseau, Gilles Salles, Bertrand Coiffier, Françoise Berger, Rémi Houlgatte.   

Abstract

Non-germinal center small B-cell lymphomas represent a heterogeneous group of non-Hodgkin lymphomas, the most frequent histologic subtypes being small lymphocytic lymphoma (SLL), splenic marginal zone B-cell lymphoma (MZL), and mantle cell lymphoma (MCL). In order to identify genomic signatures specific for each disease, we analyzed 128 primary tumors using high-density microarrays. Several clusters of genes significantly discriminated the 3 histologic subtypes. Genes associated with cell adhesion, angiogenesis, and inhibition of apoptosis were up-regulated in SLL. Genes associated with intracellular signaling via the AKT1 pathway were up-regulated in splenic MZL. Genes associated with cell cycle control and multidrug resistance were up-regulated in MCL. Using 44 genes selected within the gene clusters discriminant for the 3 lymphoma subtypes, we generated a class prediction score that allowed us to classify the 3 entities in 96% of the cases, including borderline cases. Whereas specific transcriptional profiles easily distinguished all MZL samples, SLL samples, and most of the MCL samples into separate groups, few MCL cases exhibited MZL-type transcriptional profiles. This study demonstrates that SLL, splenic MZL, and MCL possess specific transcriptional profiles that may be relevant to the pathogenesis and the diagnosis of these histologic subtypes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14630827     DOI: 10.1182/blood-2003-06-2160

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Parallel gene expression profiling of mantle cell lymphoma - how do we transform 'omics data into clinical practice.

Authors:  Ek Sara; Carl Ak Borrebaeck
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

2.  CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Authors:  Lucile Baseggio; Alexandra Traverse-Glehen; Florence Petinataud; Evelyne Callet-Bauchu; Françoise Berger; Martine Ffrench; Chantal Marie Couris; Catherine Thieblemont; Dominique Morel; Bertrand Coiffier; Gilles Salles; Pascale Felman
Journal:  Haematologica       Date:  2009-12-16       Impact factor: 9.941

3.  Molecular characteristics of mantle cell lymphoma presenting with clonal plasma cell component.

Authors:  Carlo Visco; Sylvia Hoeller; Jeffrey T Malik; Zijun Y Xu-Monette; Michele L Wiggins; Jessica Liu; Warren G Sanger; Zhongfeng Liu; Julie Chang; Erik A Ranheim; Joel F Gradowski; Sergio Serrano; Huan-You Wang; Qingquan Liu; Sandeep Dave; Brian Olsen; Randy D Gascoyne; Elias Campo; Steven H Swerdlow; Wing C Chan; Alexander Tzankov; Ken H Young
Journal:  Am J Surg Pathol       Date:  2011-02       Impact factor: 6.394

4.  Distinction between asymptomatic monoclonal B-cell lymphocytosis with cyclin D1 overexpression and mantle cell lymphoma: from molecular profiling to flow cytometry.

Authors:  Blanca Espinet; Ana Ferrer; Beatriz Bellosillo; Lara Nonell; Antonio Salar; Concepción Fernández-Rodríguez; Eulàlia Puigdecanet; Javier Gimeno; Mar Garcia-Garcia; Maria Carmen Vela; Elisa Luño; Rosa Collado; José Tomás Navarro; Esmeralda de la Banda; Pau Abrisqueta; Leonor Arenillas; Cristina Serrano; Josep Lloreta; Belén Miñana; Andrea Cerutti; Lourdes Florensa; Alberto Orfao; Ferran Sanz; Francesc Solé; David Dominguez-Sola; Sergio Serrano
Journal:  Clin Cancer Res       Date:  2013-12-18       Impact factor: 12.531

Review 5.  NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors.

Authors:  Grégory Chevillard; Volker Blank
Journal:  Cell Mol Life Sci       Date:  2011-06-18       Impact factor: 9.261

6.  Surgical management of splenic marginal zone lymphoma.

Authors:  N D Kennedy; G N Lê; M E Kelly; T Harding; K Fadalla; D C Winter
Journal:  Ir J Med Sci       Date:  2017-10-17       Impact factor: 1.568

7.  Candidate genes contributing to the aggressive phenotype of mantle cell lymphoma.

Authors:  Sarah E Henson; Travis Morford; Mary-Pat Stein; Randolph Wall; Cindy S Malone
Journal:  Acta Histochem       Date:  2010-12-09       Impact factor: 2.479

8.  Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.

Authors:  Catherine Thieblemont; Delphine Rolland; Lucile Baseggio; Pascale Felman; Sophie Gazzo; Evelyne Callet-Bauchu; Alexandra Traverse-Glehen; Rémi Houlgatte; Kai Fu; Dennis Weisenburger; Daphne De Jong; Elaine S Jaffe; Andreas Rosenwald; German Ott; Bertrand Coiffier; Françoise Berger
Journal:  Leuk Lymphoma       Date:  2008-07

9.  [Splenic marginal zone B cell lymphomas].

Authors:  M M Ott; H K Müller-Hermelink
Journal:  Pathologe       Date:  2008-03       Impact factor: 1.011

10.  Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma.

Authors:  Delphine Rolland; Valérie Camara-Clayette; Aurélie Barbarat; Gilles Salles; Bertrand Coiffier; Vincent Ribrag; Catherine Thieblemont
Journal:  Cancer Chemother Pharmacol       Date:  2007-07-18       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.